LOINC Code 104790-1: Medication maximum dose allowed period Medication
104790-1 is a LOINC code used to identify Medication maximum dose allowed period Medication in laboratory and clinical observation data. You may see this code in lab systems, lab reports, EHR exports, interoperability feeds, or other structured clinical data exchanges. LOINC codes identify tests, measurements, observations, survey items, and clinical questions in a standardized way. It is associated with the component Medication maximum dose allowed period. It is commonly used with the system or sample type Medication.
What is this code?
LOINC codes identify tests, measurements, observations, survey items, and clinical questions in a standardized way. It is associated with the component Medication maximum dose allowed period. It is commonly used with the system or sample type Medication.
When is it used?
- Used in lab systems, EHRs, and clinical data exchange.
- May identify a test, observation, survey item, or clinical document request rather than a diagnosis.
- Status: ACTIVE
- Order vs observation: Both
What it does not mean
- The code identifies the observation or test, not the actual result.
Key facts
- Medication maximum dose allowed period Medication
- Medication maximum dose allowed period
- The period of time over which a combined maximum dose of a medication may be safely administered.
- Med; Med max dose; Med max dose allowed period; MEDS; Point in time; QNT; Quan; Quant; Quantitative; Random
Where you may see this code
You may see this code in lab systems, lab reports, EHR exports, interoperability feeds, or other structured clinical data exchanges.
Common synonyms
Frequently asked questions
About this content
This page is prepared by HealthAssure's clinical team using official coding standards from LOINC. AI tools assist with drafting explanations, which are then reviewed and verified by healthcare professionals for accuracy. This content is for informational purposes and does not replace professional medical advice. Meet our team.